American Academy of Neurology Guideline Summary for Clinicians: Immunotherapy for Guillain-Barre Syndrome

QualityTool

American Academy of Neurology Guideline Summary for Clinicians: Immunotherapy for Guillain-Barre Syndrome

Description

This tool is an evidence-based statement to guide physicians in the management of Guillain-Barré syndrome (GBS).

This tool summarizes the evidence for immunotherapy in GBS management for the following treatments:

  • Plasma exchange
  • IV immunoglobulin
  • Combined treatments
  • Corticosteroids
  • Cerebrospinal fluid filtration
  • Immunoabsorption

Developer:

American Academy of Neurology

Funding Sources:

American Academy of Neurology

History

Release Date: 2003
Original Summary: October 2004
Last Updated: 07/31/13

QualityTool Classification

Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.